LA MENDOLA, DIEGO
 Distribuzione geografica
Continente #
NA - Nord America 10.872
AS - Asia 5.995
EU - Europa 4.168
SA - Sud America 983
AF - Africa 251
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 22.280
Nazione #
US - Stati Uniti d'America 10.530
SG - Singapore 1.728
CN - Cina 1.644
IT - Italia 1.387
HK - Hong Kong 1.195
SE - Svezia 870
BR - Brasile 841
VN - Vietnam 513
BG - Bulgaria 374
CA - Canada 252
DE - Germania 241
FR - Francia 219
FI - Finlandia 211
GB - Regno Unito 204
UA - Ucraina 179
RU - Federazione Russa 175
TR - Turchia 158
KR - Corea 155
JP - Giappone 148
IN - India 114
SN - Senegal 104
CH - Svizzera 83
AT - Austria 72
BD - Bangladesh 57
IQ - Iraq 55
AR - Argentina 47
CI - Costa d'Avorio 41
MX - Messico 39
ID - Indonesia 32
SA - Arabia Saudita 32
NL - Olanda 27
UZ - Uzbekistan 27
EC - Ecuador 25
ES - Italia 25
PK - Pakistan 24
ZA - Sudafrica 24
BE - Belgio 21
PL - Polonia 21
KE - Kenya 20
CO - Colombia 17
JO - Giordania 14
MA - Marocco 14
IL - Israele 13
OM - Oman 13
DZ - Algeria 11
HU - Ungheria 11
PE - Perù 11
UY - Uruguay 11
PY - Paraguay 10
TT - Trinidad e Tobago 10
VE - Venezuela 10
MY - Malesia 9
PH - Filippine 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
NP - Nepal 8
TN - Tunisia 8
AL - Albania 7
BJ - Benin 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
GT - Guatemala 6
JM - Giamaica 6
PA - Panama 6
PT - Portogallo 6
AZ - Azerbaigian 5
BB - Barbados 5
EG - Egitto 5
IE - Irlanda 5
LT - Lituania 5
NG - Nigeria 5
HN - Honduras 4
KG - Kirghizistan 4
KZ - Kazakistan 4
PS - Palestinian Territory 4
RO - Romania 4
XK - ???statistics.table.value.countryCode.XK??? 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HR - Croazia 3
IR - Iran 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
AU - Australia 2
BH - Bahrain 2
BW - Botswana 2
DK - Danimarca 2
GE - Georgia 2
KW - Kuwait 2
MN - Mongolia 2
MU - Mauritius 2
NI - Nicaragua 2
RS - Serbia 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CD - Congo 1
Totale 22.260
Città #
Woodbridge 1.315
Hong Kong 1.185
Singapore 1.032
Ashburn 1.007
Ann Arbor 821
Houston 722
Fairfield 695
Chandler 619
San Jose 548
Santa Clara 540
Milan 506
Shanghai 380
Dallas 378
Sofia 374
Beijing 323
Wilmington 282
Seattle 266
Cambridge 248
New York 233
Jacksonville 223
Ottawa 197
Princeton 194
Boardman 193
Hefei 184
Los Angeles 157
Lawrence 150
Seoul 148
Council Bluffs 143
Tokyo 140
Ho Chi Minh City 138
Lauterbourg 137
Medford 131
Nanjing 125
Serra 121
Dakar 104
Hanoi 96
Des Moines 90
Helsinki 74
Pisa 74
Izmir 71
Bern 69
Buffalo 66
Redondo Beach 65
São Paulo 64
Istanbul 59
Vienna 57
London 55
Dearborn 53
Nanchang 52
Florence 46
Munich 45
Jüchen 44
Rome 44
Abidjan 41
San Diego 39
Columbus 38
Dong Ket 38
Lancaster 34
Guangzhou 32
Rio de Janeiro 29
Frankfurt am Main 28
The Dalles 28
Boulder 27
Ogden 27
Shenyang 25
Tashkent 25
Orem 23
Hebei 21
Kunming 21
Nuremberg 20
Brussels 19
Turku 19
Nairobi 18
Warsaw 18
Catania 17
Changsha 17
Dhaka 17
Fuzhou 17
Lucca 17
Baghdad 16
Fort Wayne 16
Jiaxing 16
Paris 16
Redwood City 16
Livorno 15
Salvador 15
Tianjin 15
Amman 14
Belo Horizonte 14
Chennai 14
Da Nang 14
Norwalk 14
Riyadh 14
Turin 14
Washington 14
Chicago 13
Jakarta 13
Porto Alegre 13
Pune 13
Toronto 13
Totale 16.040
Nome #
Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties 252
A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt3)]+ pharmacophore is highly cytotoxic against ovarian cancer cells 220
Prion proteins leading to neurodegeneration 218
A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation 214
Copper(II) complexes with chicken prion repeats: influence of proline and tyrosine residues on the coordination features 209
Neurotrophic Activity and Its Modulation by Zinc Ion of a Dimeric Peptide Mimicking the Brain-Derived Neurotrophic Factor N-Terminal Region 203
A thermodynamic and spectroscopic study on the copper(II) complexes with hexarepeats fragments of the avian prion protein 198
An NMR and Molecular Dynamics investigation of the avian prion hexarepeat conformational features in solution 197
Spectroscopic characterization of PEG amylin derivatives 194
Membrane Interactions and Conformational Preferences of Human and Avian Prion N-Terminal Tandem Repeats: The Role of Copper(II) Ions, pH, and Membrane Mimicking Environments 191
Determination of the conformation of the human VDAC1 N-terminal peptide, a protein moiety essential for the functional properties of the pore 189
New glycosidic derivatives of histidine-containing dipeptides with antioxidant properties and resistant to carnosinase activity 189
Peptides and their Metal Complexes in Neurodegenerative Diseases: from Structural Studies to Nanomedicine Prospects. 189
Synthesis and antioxidant activity of new homocarnosine beta-cyclodextrin conjugates 182
Copper(II) complexes with beta-cyclodextrin-homocarnosine conjugates and their antioxidant activity 179
Environmental effects on conformational diseases. Reactive oxygen species and membrane interactions with prion, amylin and their peptide fragments 172
Zinc(II) interactions with Brain-Derived Neurotrophic Factor N-terminal peptide fragments: inorganic features and biological perspectives 171
Coordination features of prion protein domains 170
Copper, BDNF and its N-terminal Domain: Inorganic Features and Biological Perspectives 170
Synthesis of new carnosine derivatives of beta-cyclodextrin and their hydroxyl radical scavanger ability 169
Copper (II) ions modulate Angiogenin activity in human endothelial cells 168
Intracellular bioinorganic chemistry and cross talk among different - omics 167
Transition metal complexes of terminally protected peptides containing hystidyl residues 166
Copper(II) interaction with unstructured prion domain outside the octarepeat region: speciation, stability and binding details of copper(II) complexes with PrP106-126 peptides” 165
A tunable nanoplatform of nanogold functionalised with Angiogenin peptides for anti-angiogenic therapy of brain tumours 165
Copper(II) complex formation with a linear peptide encompassing the putative cell binding site of angiogenin 162
Binding of Zn(II) to Tropomyosin Receptor Kinase A in Complex with Its Cognate Nerve Growth Factor: Insights from Molecular Simulation and in Vitro Essays 160
Copper(II) interaction with peptide fragments of histidine-proline-rich glycoprotein: speciation, stability and binding details 160
Surface immobilization of fibronectin-derived PHSRN peptide on functionalized polymer films - Effects on fibroblast spreading 159
Potentiometric, spectroscopic and biological activity studies of sod mimics containing carnosine 158
Adsorption of NGF and BDNF derived peptides on gold surfaces 158
Neurotrophin-mimicking peptides at the biointerface with gold respond to copper ion stimuli 158
Biological applications of thiocarbohydrazones and their metal complexes: A perspective review 158
Conformational properties and functional role of the VDAC N-terminal peptide 157
Copper ion interaction with the RNase catalytic site fragment of the angiogenin protein: an experimental and theoretical investigation 157
Medicinal Hypervalent Tellurium Prodrugs Bearing Different Ligands: A Comparative Study of the Chemical Profiles of AS101 and Its Halido Replaced Analogues 156
Cyclodextrins functionalised with etodolac as specific site release agents 156
Copper coordination to the putative cell binding site of angiogenin: a DFT investigation 156
Copper binding to naturally occurring, lactam form of angiogenin differs from that to recombinant protein, affecting their activity 156
New Insight in Copper-Ion Binding to Human Islet Amyloid: The Contribution of Metal-Complex Speciation To Reveal the Polypeptide Toxicity 156
PEG-amylin fragments as models for conformational studies 155
Probing the copper(II) binding features of Angiogenin. Similarities and differences between a N-terminus peptide fragment and the recombinant human protein. 155
Electrostatically driven interaction of silica-supported lipid bilayer nanoplatforms and a nerve growth factor-mimicking peptide 155
AS101: An overview on a leading tellurium-based prodrug 154
Dimers of functionalized beta-Cyclodextrins as Superoxide Dismutase Models 153
Spectroscopic characterization of doppel peptide fragments and their complex species with Cu(II) 153
A Small Linear Peptide Encompassing the NGF N-Terminus Partly Mimics the Biological Activities of the Entire Neurotrophin in PC12 Cells 150
Electrospray mass spectrometric studies of L-carnosine (beta-alanyl-L-histidine) complexes with copper(II) or zinc ions in aqueous solution 148
Inorganic Drugs as a Tool for Protein Structure Solving and Studies on Conformational Changes 147
Sintesi di ciclodestrine funzionalizzate con Etodolac come agenti di rilascio sito specifico 145
Angiogenesis in Disease 144
A Doppel alpha-Helix Peptide Fragment Mimics the Copper(II) Interactions with the Whole Protein 144
Interactions of Cu(2+) with prion family peptide fragments: Considerations on affinity, speciation and coordination 143
Selectively funtionalized cyclodextrins and their metal complexes 142
Unveiling the role of histidine and tyrosine residues on the conformation of the avian prion hexarepeat domain 142
Interactions of Cu2+ with the N-terminus fragment of brain-derived neurotrophic factor encompassing the recognition domain of the TrkB receptor 142
Copper(II) complexes with peptide fragments encompassing the sequence 122-130 of human doppel protein 142
The Copper(II)-Assisted Connection between NGF and BDNF by Means of Nerve Growth Factor-Mimicking Short Peptides 142
Anti-Staphylococcal Activity of the Auranofin Analogue Bearing Acetylcysteine in Place of the Thiosugar: An Experimental and Theoretical Investigation 142
Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt3)I: A Theoretical and Experimental Study 141
Copper(II) assisted self-assembly of functionalized beta-Cyclodextrins with beta-alanyl-L-histidine 140
Potentiometric and spectroscopic characterization of copper(II) complexes with the chicken prion hexarepeat-containing peptides 140
Probing the Residual Structure in Avian Prion Hexarepeats by CD, NMR and MD Techniques 140
Antimicrobial and Antibiofilm Activity of Auranofin and Its Two Derivatives Bearing Naproxen and Acetylcysteine as Ligands Against Staphylococci 140
Diruthenium(ii,iii) paddlewheel complexes: effects of bridging and axial ligands on anticancer properties 140
The Inorganic Perspective of Nerve Growth Factor: Interactions of Cu(2+) and Zn(2+) with the N-Terminus Fragment of Nerve Growth Factor Encompassing the Recognition Domain of the TrkA Receptor 139
The inorganic perspectives of neurotrophins and Alzheimer's disease 138
Copper(II) complexes with an avian prion N-terminal region and their potential SOD-like activity 137
Copper(II) complexes with peptides based on the second cell binding site of fibronectin: Metal coordination and ligand exchange kinetics 133
hNGF peptides elicit the NGF-TrkA signalling pathway in cholinergic neurons and retain full neurotrophic activity in the DRG assay 133
Copper(II) interaction with human Angiogenin protein and related peptide fragments 132
Peptides derived from the histidine-proline rich glycoprotein bind copper ions and exhibit anti-angiogenic properties 132
Carnosine derivatives, a process for the preparation thereof and pharmaceutical compositions containing them 131
Functional mimics of Cu,Zn, Superoxide Dismutase 131
Neurotrophins and biometals: inorganic features and biological perspectives 131
Cisplatin binding to angiogenin protein: new molecular pathways and targets for the drug's anticancer activity 128
ESI-MS studies on copper(II) ion assisted self-assembly of beta-alanyl-L-histidine beta-cyclodextrin derivative 128
Surface adsorption of fibronectin-derived peptide fragments: the influence of electrostatics and hydrophobicity for endothelial cells adhesion 128
The ionophoric activity of a pro-apoptotic vegf165 fragment on huvec cells 128
Transition metal complexes of peptide fragments of prion proteins 126
Antioxidant properties of beta-cyclodextrin homocarnosine derivatives and of their copper(II) complexes 126
The Inorganic Perspective of VEGF: Interactions of Cu2 + with Peptides Encompassing a Recognition Domain of the VEGF Receptor 125
Characterization of copper(II) and zinc(II) complexes with the N-terminal domain of Nerve Growth Factor 124
The Synthesis and Conformation of beta-Cyclodextrins Functionalized with Enantiomers of Boc-Carnosine 123
Conformational study of avian prion hexarepeat in aqueosu solution 123
Nerve growth factor catches copper in neuronal inning 123
Non‐medical applications of inorganic medicines. A switch based on mechanistic knowledge 122
Metal ions and the clearance of misfolded proteins 122
Copper(II) interaction with histidine-proline rich glycoprotein fragments and their anti-angiogenic activity 122
SOD-like activity of copper(II) complexes of beta-cyclodextrins functionalized with carnosine 122
null 122
Copper(II) coordination properties of the integrin ligand sequence PHSRN and its new beta-cyclodextrin conjugates 122
Ruthenium(II) 1,4,7-trithiacyclononane complexes of curcumin and bisdemethoxycurcumin: Synthesis, characterization, and biological activity 122
A Graphene Oxide-Angiogenin Theranostic Nanoplatform for the Therapeutic Targeting of Angiogenic Processes: The Effect of Copper-Supplemented Medium 121
Metallomics and New Targets in Metal-Based Drug Discovery. 121
The curious case of opossum prion: A physicochemical study on copper(ii) binding to the bis-decarepeat fragment from the protein N-terminal domain 121
From conventional therapy to novel nano-based approaches. A focus on prostate cancer 120
Characterization of copper(II) complex species with human doppel protein fragments 120
Copper(II) and Zinc(II) interactions with antiangiogenic peptide fragments derived from the Histidine-rich glycoprotein 120
Conformational features and copper(II) binding sites of avian prion hexarepeat 119
Totale 15.128
Categoria #
all - tutte 62.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.720


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021253 0 0 0 0 0 0 0 0 0 0 77 176
2021/20221.671 42 118 42 108 319 228 47 61 97 29 115 465
2022/20232.000 305 242 151 178 181 283 28 147 348 17 80 40
2023/20241.662 231 205 184 119 322 231 76 47 23 21 51 152
2024/20254.995 19 202 37 231 365 456 476 330 482 667 539 1.191
2025/20265.404 270 764 628 639 444 515 827 284 360 535 138 0
Totale 22.654